Trade Recordati SPA - RECm CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.22 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.018641% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | -0.003582% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 0.1 | ||||||||
| Currency | EUR | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | Italy | ||||||||
| Commission on trade | 0% |
| Prev. Close | 54.79 |
| Open | 54.54 |
| 1-Year Change | 4.86% |
| Day's Range | 53.89 - 54.69 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Feb 21, 2025 | 53.99 | -0.45 | -0.83% | 54.44 | 54.84 | 53.84 |
| Feb 20, 2025 | 54.79 | -0.85 | -1.53% | 55.64 | 55.84 | 54.74 |
| Feb 19, 2025 | 55.69 | 0.40 | 0.72% | 55.29 | 57.04 | 55.29 |
| Feb 18, 2025 | 59.74 | -0.19 | -0.32% | 59.93 | 59.93 | 59.24 |
| Feb 17, 2025 | 59.84 | 0.50 | 0.84% | 59.34 | 60.03 | 59.09 |
| Feb 14, 2025 | 59.39 | -0.05 | -0.08% | 59.44 | 60.18 | 58.99 |
| Feb 13, 2025 | 60.28 | 1.64 | 2.80% | 58.64 | 60.38 | 58.64 |
| Feb 12, 2025 | 58.99 | 0.35 | 0.60% | 58.64 | 59.14 | 58.49 |
| Feb 11, 2025 | 58.54 | 0.10 | 0.17% | 58.44 | 58.54 | 57.94 |
| Feb 10, 2025 | 58.39 | 0.25 | 0.43% | 58.14 | 58.79 | 58.09 |
| Feb 7, 2025 | 58.34 | 0.85 | 1.48% | 57.49 | 58.89 | 57.49 |
| Feb 6, 2025 | 59.44 | 0.20 | 0.34% | 59.24 | 59.64 | 59.14 |
| Feb 5, 2025 | 59.24 | 0.60 | 1.02% | 58.64 | 59.44 | 58.64 |
| Feb 4, 2025 | 59.24 | 0.05 | 0.08% | 59.19 | 59.39 | 58.54 |
| Feb 3, 2025 | 59.09 | 1.30 | 2.25% | 57.79 | 59.39 | 57.79 |
| Jan 31, 2025 | 58.69 | -0.40 | -0.68% | 59.09 | 59.09 | 58.49 |
| Jan 30, 2025 | 58.89 | 0.75 | 1.29% | 58.14 | 58.94 | 58.04 |
| Jan 29, 2025 | 57.94 | 0.65 | 1.13% | 57.29 | 58.54 | 57.29 |
| Jan 28, 2025 | 57.54 | 0.95 | 1.68% | 56.59 | 57.69 | 56.59 |
| Jan 27, 2025 | 56.64 | 1.15 | 2.07% | 55.49 | 56.74 | 55.49 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Recordati Company profile
About Recordati Industria Chimica e Farma SpA
Recordati Industria Chimica e Farmaceutica SpA is an Italy-based group engaged in the research, development, manufacture and marketing of pharmaceuticals. It promotes a wide range of pharmaceuticals, both proprietary and under license, in a number of therapeutic areas, such as Antibiotics and Antiviral, Cardiovascular, Central nervous system, Dermatological, Gastroenterology, Genital-urinary system, Muscular-skeletal disorders and pain therapy, Obstetrics and Gynecology and over the counter (OTC) pharmaceuticals. The Company is engaged in the research and development of new drug entities within the cardiovascular and urogenital therapeutic areas and of treatments for rare diseases. It’s product is ZANIDIP, a latest generation calcium-channel blocker for the treatment hypertension. It operates through Italchimici SpA, Pro Farma AG and North American marketing rights to Cystadane. The Company owns and operates through Natural Point srl also in the food supplement sector.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Recordati Industria Chimica e Farma SpA revenues increased 9% to EUR1.58B. Net income increased 9% to EUR386M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Dividend per share increased from EUR1.05 to EUR1.10. Basic Earnings per Share excluding Extraordinary Items increased from EUR1.73 to EUR1.87.
| Industry: | Pharmaceuticals (NEC) |
Via M. Civitali, 1
MILANO
MILANO 20148
IT
News
Microsoft Stock Price Forecast for 2025 and beyond: Third party price target
We assess the likely level of the Microsoft stock price in 5 years, and possible drivers behind the stock’s past performance. Read on...
18:29, 7 February 2025
Ripple XRP price prediction: Third-party price target
Discover the ripple (XRP) price predictions for 2025 and beyond, with analyst price targets and CFDs trading strategies on Capital.com
15:29, 6 February 2025
Apple (AAPL) stock price forecast: third-party price target
We looked at the forecasts for Apple stock in 10 years to see where the price would likely be at that point and the challenges the company could face. Read more.
11:22, 6 February 2025
FARTCOIN price prediction: Third-party price target
Read our FARTCOIN price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:18, 29 January 2025
MELANIA coin ($MELANIA) price prediction: Third party price target
Read our MELANIA crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts.
11:33, 22 January 2025
TRUMP coin ($TRUMP) price prediction: third-party price target
Read our TRUMP crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:52, 22 January 2025
Ethereum price prediction: Third party data round up
What is the outlook for ETH as a long-term investment?
16:37, 7 January 2025People also watch
Still looking for a broker you can trust?
Join the 690,000+ traders worldwide that chose to trade with Capital.com